Analysis of effectiveness of a surgical treatment algorithm for basal cell carcinoma
An. bras. dermatol
;
91(6): 726-731, Nov.-Dec. 2016. tab, graf
Article
in English
| LILACS
| ID: biblio-837995
ABSTRACT
Abstract BACKGROUND:
Surgical excision is the treatment of choice for basal cell carcinoma and micrographic surgery considered the gold standard, however not yet used routinely worldwide available, as in Brazil. Considering this, a previously developed treatment guideline, which the majority of tumors were treated by conventional technique (not micrographic) was tested.OBJECTIVE:
To establish the recurrence rate of basal cell carcinomas treated according to this guideline.METHOD:
Between May 2001 and July 2012, 919 basal cell carcinoma lesions in 410 patients were treated according to the proposed guideline. Patients were followed-up and reviewed between September 2013 and February 2014 for clinical, dermatoscopic and histopathologic detection of possible recurrences.RESULTS:
After application of exclusion criteria, 520 lesions were studied, with 88.3% primary and 11.7% recurrent tumors. Histological pattern was indolent in 85.5%, 48.6% were located in high risk areas and 70% small tumors. Only 7.3% were treated by Mohs micrographic surgery. The recurrence rate, in an average follow-up period of 4.37 years, was 1.3% for primary and 1.63% for recurrent tumors. Studylimitations:
unicenter study, with all patients operated on by the same surgeon.CONCLUSION:
The treatment guideline utilized seems a helpful guide for surgical treatment of basal cell carcinoma, especially if micrographic surgery is not available.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Skin Neoplasms
/
Algorithms
/
Carcinoma, Basal Cell
Type of study:
Etiology study
/
Evaluation studies
/
Practice guideline
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2016
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal Fluminense/BR
Similar
MEDLINE
...
LILACS
LIS